RPTEC/TERT12024-01-02T09:29:45+00:00

Kidney

RPTEC/TERT1

Evercyte ́s human renal proximal tubular epithelial cell line RPTEC/TERT1 can be grown without limitations while maintaining expression of cell type specific markers and function. Therefore, these cells are useful to study kidney transport functions, kidney diseases or diabetes and to test new drugs for cytotoxic effects. Additionally, the cell line is the perfect starting material for genetic engineering to create important disease models.

determination of IC50 values of drugs on relevant and standardizable human telomerized cells

Print Friendly, PDF & Email

from

€ 1600,–

RPTEC/TERT1
Cat#: CHT-003-0002

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Products

ProxUp2 cell culture medium for growth of RPTEC/TERT1

Watch our RPTEC/TERT1 cells differentiate

video from Paul Jennings, Innsbruck Medical University

RPTEC/TERT1 kidney-on-a-chip model

In collaboration with OOAC leader Nortis

cisplatin-induced toxicity

RPTEC/TERT1 cells as relevant in vitro model to study kidney toxicity

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

RPTEC/TERT1
Cat#: CHT-003-0002

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Title

Go to Top